Seven Eight Capital’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-29,960
| Closed | -$821K | – | 406 |
|
|
2024
Q3 | $821K | Buy |
29,960
+20,298
| +210% | +$556K | 0.07% | 453 |
|
|
2024
Q2 | $236K | Buy |
+9,662
| New | +$236K | 0.02% | 642 |
|
|
2019
Q1 | – | Sell |
-70,061
| Closed | -$2.04M | – | 666 |
|
|
2018
Q4 | $2.04M | Buy |
70,061
+37,895
| +118% | +$1.1M | 0.11% | 232 |
|
|
2018
Q3 | $1.48M | Buy |
+32,166
| New | +$1.48M | 0.09% | 300 |
|
|
2017
Q4 | – | Sell |
-58,500
| Closed | -$2.12M | – | 533 |
|
|
2017
Q3 | $2.12M | Buy |
+58,500
| New | +$2.12M | 0.26% | 129 |
|
|
2016
Q3 | – | Sell |
-11,500
| Closed | -$352K | – | 474 |
|
|
2016
Q2 | $352K | Buy |
11,500
+10,700
| +1,338% | +$328K | 0.12% | 239 |
|
|
2016
Q1 | $30K | Sell |
800
-800
| -50% | -$30K | 0.01% | 464 |
|
|
2015
Q4 | $69K | Buy |
+1,600
| New | +$69K | 0.05% | 406 |
|
|
2015
Q1 | – | Sell |
-1,800
| Closed | -$61K | – | 619 |
|
|
2014
Q4 | $61K | Buy |
1,800
+1,406
| +357% | +$47.6K | 0.1% | 246 |
|
|
2014
Q3 | $15.2K | Sell |
394
-1,689
| -81% | -$65.1K | 0.01% | 465 |
|
|
2014
Q2 | $81K | Buy |
+2,083
| New | +$81K | 0.08% | 320 |
|
|
2014
Q1 | – | Sell |
-1,200
| Closed | -$25K | – | 427 |
|
|
2013
Q4 | $25K | Buy |
+1,200
| New | +$25K | 0.03% | 477 |
|